Tamoxifen cytotoxicity in hepatoblastoma cells stably transfected with human CYP3A4

This publication has 23 references indexed in Scilit:

• The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.
  Carcinogenesis: Integrative Cancer Research, 2002
• High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial
  Hepatology, 2002
• Understanding the genotoxicity of tamoxifen?
  Carcinogenesis: Integrative Cancer Research, 2001
• Short-term dosing of α-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats
  Carcinogenesis: Integrative Cancer Research, 2001
• Variable contribution of cytochromes p450 2d6, 2c9 and 3a4 to the 4-hydroxylation of tamoxifen by human liver microsomes
  Biochemical Pharmacology, 1997
• The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: potential importance to its proposed anti-carcinogenic/carcinogenic actions
  Carcinogenesis: Integrative Cancer Research, 1996
• Drug toxicity mechanisms in human hepatoma HepG2 cells: cyclosporin A and tamoxifen
  Xenobiotica, 1995
• Antiestrogens and steroid hormones: Substrates of the human P-glycoprotein
  Biochemical Pharmacology, 1994
• Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes
  Biochemical Pharmacology, 1994
• Effect of Mestranol on Cell Proliferation and Angiotensinogen Production in HepG2 Cells: Relation with the Cell Cycle and Action of Tamoxifen
  Endocrinology, 1987